On the other hand, the neglected CD21hi subset that possesses a higher density of CXCR5 and increases in frequency in post-treatment LN patients, would represent those cells mentioned in the CXCL13/CXCR5 axis reports (31–33). This evidence concerns the gene CXCL13 and lobular neoplasia.